Skip to main content

Advertisement

Log in

The pathogenesis of glomerulonephritis

Problems and recent understanding

  • Editorials
  • Published:
Ricerca in clinica e in laboratorio

Summary

Progress has been made in understanding glomerulonephritis but the answers to many key questions still elude us. It appears that glomerular damage arises from immune events which result from an interaction between a susceptible individual and some environmental agents, usually an infection. In the developed world the role of the genetic constitution is predominant, whilst in the Third world the overwhelming exposure to pathogens may be crucial. Immune complex formation undoubtedly plays a major role in the initiation of glomerular injury, but deposition of soluble preformed complexes within the glomerulus now seems to be only one mechanism,in situ combination of fixed antigen and free antibody, and insoluble (precipitating) complexes both playing a part as well. New understanding of modes of damage to the glomerulus strongly implicates monocytes as injurious agents in both experimental and human nephritis, and platelets may also play a role in amplifying injury. One of the main questions is why only some forms of glomerulonephritis in only some patients progress to renal failure. Whilst continuing exposure to the antigen initiating the nephritis may be important, secondary mechanisms involving autologous antigens may be important. Further, non-immunologic mechanisms which arise from hyperperfusion of glomerular capillaries appear capable of damaging the glomerulus, and both this mechanism and proteinuria itself appear capable of inducing glomerulosclerosis. The role these non-immunologic mechanisms play may be the reason for our failure, in general, to influence the course of glomerulonephritis by manoeuvres designed to inhibit immunologic injury.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Abdou N. I., Sagawa A., Pascal E., Hevert J., Sadeghee S.: Suppressor T cell abnormality in systemic lupus erythematosus — Clin. Immunol. Immunopath.6, 192, 1976.

    CAS  Google Scholar 

  2. Adler S., Salant D. J., Dittmer J. E., Madaio M. P., Couser W. G.: Mediation of proteinuria in membranous nephropathy (MN) induced by a planted subepithelial antigen (AG). In: Abstracts, American Society of Nephrology, Washington, November 1981; p. 68A.

  3. Adler S., Wang H., Cohen A., Border W.: Electropharmacologic modulation ofin situ complex formation in experimental membranous nephropathy. In: Abstracts, American Society of Nephrology, Washington, November 1981; p. 68A.

  4. Adu D., Dobson J., Williams D. G.: DNA-anti-DNA circulating complexes in the nephritis of systemic lupus erythematosus — Clin. exp. Immunol.43, 605, 1981.

    PubMed  CAS  Google Scholar 

  5. Agnello V.: Complement deficiency states — Medicine (Baltimore)57, 1, 1978.

    CAS  Google Scholar 

  6. Amend W. J. C., Vincenti F., Feduska M. J., Salvatierra O., Johnston J., Tilney N., Garavoy M., Burwell E. L.: Recurrent systemic lupus erythematosus involving renal allografts — Ann. intern. Med.94, 444, 1981.

    PubMed  Google Scholar 

  7. Atkins R. C., Holdsworth S. R., Glasgow E. F., Mathews F. G.: The macrophage in human rapidly progressive glomerulonephritis — Lanceti, 830, 1976.

    Google Scholar 

  8. Baldwin D. S.: Nephrology forum. Chronic glomerulonephritis: non-immunologic mechanisms of progressive glomerular damage — Kidney int.21, 109, 1982.

    PubMed  CAS  Google Scholar 

  9. Barnett E. V., Knutson D. W., Abrass C. K., Chia D. S., Young L. S., Liebling M. R.: Circulating immune complexes: their immunochemistry, detection and importance — Ann. intern. Med.91, 430, 1979.

    Google Scholar 

  10. Barsotti G., Guiducci A., Ciardella F., Giovannetti S.: Effects on renal function of a low nitrogen diet supplemented with essential amino acids and keto-analogues and of haemodialysis and free protein supply in patients with chronic renal failure — Nephron27, 113, 1981.

    PubMed  CAS  Google Scholar 

  11. Bartolotti S. R., Peters D. K.: Delayed removal of renal-bound antigen in decomplemented animals with acute serum sickness — Clin. exp. Immunol.32, 199, 1978.

    PubMed  CAS  Google Scholar 

  12. Barton C. H., Vaziri N. D., Spear G. S.: Nephrotic syndrome associated with adenocarcinoma of the breast — Amer. J. Med.68, 308, 1980.

    PubMed  CAS  Google Scholar 

  13. Batsford S. R., Rohrbach R., Vogt A.: The role of change in subepithelial glomerular immune deposit formation. In: Abstracts, American Society of Nephrology, Washington, November 1981; p. 69A.

  14. Batsford S. R., Takmiya H., Vogt A.: A model ofin situ immune complex glomerulonephritis in the rat employing cationised ferritin — Clin. Nephrol.14, 211, 1980.

    PubMed  CAS  Google Scholar 

  15. Bhan A. K., Collins A. B., Schneeberger E. E., McCluskey R. T.: A cell-mediated reaction against glomerular-bound immune complexes — J. exp. Med.150, 1410, 1979.

    PubMed  CAS  Google Scholar 

  16. Bhan A. K., Schneeberger E. E., Collins A. B., McCluskey R. T.: Evidence for a pathogenic role of a cell-mediated immune mechanism in experimental glomerulonephritis — J. exp. Med.148, 246, 1978.

    PubMed  CAS  Google Scholar 

  17. Border W. A.: Immune complex detection in glomerular diseases — Nephron24, 105, 1979.

    PubMed  CAS  Google Scholar 

  18. Border W. A., Ward H. J., Kamil E. S., Cohen A. H.: Induction of membranous nephropathy in rabbits by administration of an exogenous cationic antigen: demonstration of a pathogenic role for electrical change — J. clin. Invest.69, 451, 1982.

    PubMed  CAS  Google Scholar 

  19. Boulton-Jones M., Sissons J. G. P., Naish P. F., Evans D. J., Peters D. K.: Self-induced glomerulonephritis — Brit. med. J.iii, 387, 1974.

    Google Scholar 

  20. Boyns A. R., Hardwicke J.: The relationship between circulating soluble antigen-antibody complexes and the production of chronic glomerulonephritis in the rabbit — Immunology14, 367, 1968.

    PubMed  CAS  Google Scholar 

  21. Bradfield J. W. B., Cattell V.: The mesangial cell in glomerulonephritis. I. Mechanism of hypercellularity in experimental immune complex glomerulonephritis — Lab. Invest.36, 481, 1977.

    PubMed  CAS  Google Scholar 

  22. Cameron J. S.: Clinicopathological correlations — problems and limitations — Clin. Nephrol.4, 1, 1975.

    PubMed  CAS  Google Scholar 

  23. Cameron J. S.: Platelets and glomerulonephritis — Nephron18, 253, 1977.

    PubMed  CAS  Google Scholar 

  24. Cameron J. S.: The natural history of glomerulonephritis. In:Black D. A. K., Jones N. F. (Eds): Renal disease. Oxford Sci. Publ., Oxford, 1979; p. 329.

    Google Scholar 

  25. Cameron J. S.: The natural history of glomerulonephritis. In:Kincaid-Smith P., D’Apice A. J. F., Atkins R. C. (Eds): Progress in glomerulonephritis. John Wiley and Sons, New York, 1979; p. 1.

    Google Scholar 

  26. Cameron J. S.: Clinicopathological correlations in glomerular disease. In: Kidney disease, present status. IAP Monographs no. 20, Williams and Wilkins, Baltimore, 1979; p. 76.

    Google Scholar 

  27. Cameron J. S.: Pathogenesis and treatment of membranous nephropathy — Kidney int.15, 88, 1979.

    PubMed  CAS  Google Scholar 

  28. Cameron J. S.: Glomerulonephritis. In:Marsh F. P. (Ed.): A textbook of modern nephrology. Heinemann, London, 1982. (In press).

    Google Scholar 

  29. Cameron J. S.: The treatment of immunologically mediated renal disease. In:Zabriskie J., Fillit H. M. (Eds): Immunology of the kidney. John Wiley and Sons, New York, 1982. (In press).

    Google Scholar 

  30. Cameron J. S., Clark W. F.: A role for insoluble complexes in glomerulonephritis? — Clin. Nephrol., 1982. (In press).

  31. Cattell V., Jameson S. W.: The origin of glomerular crescents in experimental nephrotoxic serum nephritis in man — Lab. Invest.39, 584, 1978.

    PubMed  CAS  Google Scholar 

  32. Chatenoud L., Bach M.-A.: Abnormalities of T cell subsets in glomerulonephritis and systemic lupus erythematosus — Kidney int.20, 267, 1981.

    PubMed  CAS  Google Scholar 

  33. Clark W. F., Friesen M., Linton A. L., Lindsay R. M.: The platelet as mediator of tissue damage in immune complex glomerulonephritis — Clin. Nephrol.6, 287, 1976.

    PubMed  CAS  Google Scholar 

  34. Clark W. F., Turnbull D. I., Driedger A. A., Lindsay R. M., Linton A. L.: Intrarenal insoluble immune complex formation — J. clin. Lab. Immunol.4, 21, 1980.

    PubMed  CAS  Google Scholar 

  35. Cochrane C. G.: Mechanisms involved in the deposition of immune complexes in tissues — J. exp. Med.134, 75s, 1971.

  36. Cochrane C. G., Dixon F. J.: Antigen-antibody complex induced disease. In:Miescher P. A., Muller-Eberhard H. E. (Eds): Clinical immunopathology. Grune and Stratton, New York, 1976; p. 137.

    Google Scholar 

  37. Cochrane C. G., Hawkins D. J.: Studies on circulating immune complexes. III. Factors governing the ability of circulating complexes to localise in blood vessels — J. exp. Med.127, 137, 1968.

    PubMed  CAS  Google Scholar 

  38. Cochrane C. G., Koffler D.: Immune complex disease in experimental animals and in man — Advanc. Immunol.16, 185, 1973.

    CAS  Google Scholar 

  39. Cohen A. H., Mampaso F., Zamboni L.: Glomerular podocyte degeneration in human renal disease. An ultrastructural study — Lab. Invest.37, 30, 1977.

    PubMed  CAS  Google Scholar 

  40. Cotran R. S.: The role of monocytes and macrophages in glomerulonephritis. In: Proc. 8th Congr. Int. Soc. Nephrol., Athens, June 1981. (Introduction). Karger, Basel, 1981; p. 853.

    Google Scholar 

  41. Couser W. G.: What are circulating immune complexes doing in glomerulonephritis? — New Engl. J. Med.304, 1230, 1981.

    PubMed  CAS  Google Scholar 

  42. Couser W. G., Salant D.:In situ complex formation and glomerular injury — Kidney int.17, 1, 1980.

    PubMed  CAS  Google Scholar 

  43. Danno K., Fukuyama K., Epstein W. L.: Renal deposition of antinuclear antibody in athymic mice infected withSchistosoma mansoni — Lab. Invest.40, 358, 1979.

    PubMed  CAS  Google Scholar 

  44. Dausset J., Contu L.: The MHC and immune response in man. In:Fougereau M., Dausset J. (Eds): Immunology 80. Pergamon Press, New York, 1980; p. 503.

    Google Scholar 

  45. Davies D. J., Brewer D. B., Hardwicke J.: Urinary proteins and glomerular morphometry in protein overload proteinuria — Lab. Invest.38, 232, 1978.

    PubMed  CAS  Google Scholar 

  46. Davison A., Kerr D. N. S., Cameron J. S.: Natural history of untreated idiopathic glomerulonephritis in adults. In: Abstracts, 8th Congr. Int. Soc. Nephrol., Athens, June 1981, no. CN-196; p. 291.

  47. Deen W. M., Maddox D. A., Robertson C. R., Brenner B. M.: Dynamics of glomerular ultrafiltration in the rat. VII. Response to reduced renal mass — Amer. J. Physiol.227, 556, 1974.

    PubMed  CAS  Google Scholar 

  48. Deuel T. F., Senior R. M., Chang D., Griffin G. L., Henrikson R. S., Kaiser E. T.: Platelet factor 4 is chemotactic for neutrophils and monocytes — Proc. nat. Acad. Sci. (Wash.)78, 4584, 1981.

    CAS  Google Scholar 

  49. Dixon F. J.: The pathogenesis of glomerulonephritis — Amer. J. Med.44, 493, 1968.

    PubMed  CAS  Google Scholar 

  50. Dixon F. J., Feldman J. D., Vasquez J. J.: Experimental glomerulonephritis. The pathogenesis of a laboratory model resembling the spectrum of human glomerulonephritis — J. exp. Med.113, 899, 1961.

    PubMed  CAS  Google Scholar 

  51. Dubois C. H., Foidart J. B., Hautier M. B., Dechenne C. A., Lemaire M. J., Mahieu P. R.: Proliferative glomerulonephritis in rats: evidence that mononuclear phagocytes infiltrating the glomerulus stimulate the proliferation of endothelial and mesangial cells — Europ. J. clin. Invest.11, 91, 1981.

    PubMed  CAS  Google Scholar 

  52. Ehrich W. E., Forman C. W., Seifer J.: Diffuse glomerular nephritis and lipid nephrosis. Correlation of clinical, morphological and experimental observations — Arch. Path.54, 463, 1952.

    CAS  Google Scholar 

  53. El-Nahas A. M., Paraskevakou H., Evans D. J., Rees A. J.: Protection from renal failure after subtotal nephrectomy in rats by dietary protein restriction — Clin. Sci.62, 33P, 1981. (Abstract).

  54. Farquhar M. G., Vernier R. L., Good R. A.: Electron microscope study of glomerulus in nephrosis, glomerulonephritis and lupus erythematosus — J. exp. Med.106, 649, 1951.

    Google Scholar 

  55. Fillastre J. P.: Drug-induced glomerulonephritis — Dialysis Transplant.10, 716, 1981.

    Google Scholar 

  56. Fischer E., Camus D., Santoro F., Capron A.:Schistosoma mansoni: autoantibodies and polyclonal B cell activation in infected mice — Clin. exp. Immunol.46, 89, 1981.

    PubMed  CAS  Google Scholar 

  57. Fleuren G., Grond J., Hoedemaker P. J.:In situ formation of subepithelial glomerular immune complexes in passive serum sickness — Kidney int.17, 631, 1980.

    PubMed  CAS  Google Scholar 

  58. Ford P. M., Kosatka I.: A mechanism of enhancement of immune complex deposition followingin situ complex formation in the mouse glomerulus — Immunology43, 433, 1981.

    PubMed  CAS  Google Scholar 

  59. Gabbiani G., Badonnel M. C., Vassalli P.: Experimental focal glomerular lesions elicited by insoluble immune complexes. Ultrastructural and immunofluorescent studies — Lab. Invest.32, 33, 1975.

    PubMed  CAS  Google Scholar 

  60. George C. R. P., Clark W. F., Cameron J. S.: The role of platelets in glomerulonephritis — Advanc. Nephrol.4, 19, 1975.

    Google Scholar 

  61. Germuth F. G. Jr.: A comparative histologic and immunologic study in rabbits of induced hypersensitivity of the serum sickness type — J. exp. Med.97, 257, 1953.

    PubMed  Google Scholar 

  62. Germuth F. G. Jr.,Rodriguez E. L.: Immunopathology of the renal glomerulus. Immune complex deposit and anti-basement membrane disease — Little, Brown and Co., Boston, 1973.

    Google Scholar 

  63. Germuth F. G. Jr.,Rodriguez E., Lorelle C. A., Trump E. I., Milano L. L., Wise O.: Passive immune complex glomerulonephritis in mice: models for various lesions found in human disease. I. High avidity complexes and mesangiopathic glomerulonephritis — Lab. Invest.41, 360, 1979.

    PubMed  Google Scholar 

  64. Germuth F. G. Jr.,Rodriguez E., Lorelle C. A., Trump E. I., Milano L. L., Wise O.: Passive immune complex glomerulonephritis in mice: models for various lesions found in human disease. II. Low avidity complexes and diffuse proliferative glomerulonephritis with subendothelial deposits — Lab. Invest.41, 366, 1979.

    PubMed  Google Scholar 

  65. Germuth F. G. Jr.,Senterfit L. B., Dreesman G. R.: Immune complex disease. V. The nature of the circulating complexes associated with glomerular alterations in the BSA rabbit system — Johns Hopk. med. J.131, 344, 1972.

    Google Scholar 

  66. Germuth F. G. Jr.,Senterfit L. B.,Pollak A. D.: Immune complex disease. I. Experimental acute and chronic glomerulonephritis — Johns Hopk. med. J.120, 225, 1967.

    Google Scholar 

  67. Germuth F. G. Jr.,Taylor J. J., Siddiqui S. Y., Rodriguez E.: Immune complex disease. VI. Some determinants of the varieties of glomerular lesions in the chronic bovine serum albumin — rabbit system — Lab. Invest.37, 162, 1977.

    PubMed  Google Scholar 

  68. Glasser R. J., Velosa J. A., Michael A. F.: Experimental model of focal sclerosis. I. Relationship to protein exaction in aminonucleoside nephrosis — Lab. Invest.36, 519, 1977.

    PubMed  CAS  Google Scholar 

  69. Glassock R. J.: A clinical and immunopathologic dissection of rapidly progressive glomerulonephritis — Nephron22, 253, 1978.

    PubMed  CAS  Google Scholar 

  70. Glassock R. J., Cohen A. H.: Secondary glomerular disease. In:Brenner B. M., Rector R. C. (Eds): The kidney. W. B. Saunders, Philadelphia, 1981; 2nd ed., p. 1493.

    Google Scholar 

  71. Glassock R. J., Cohen A. H., Bennett C. M., Martinez-Maldonado M.: Primary glomerular diseases. In:Brenner B. M., Rector R. C. (Eds): The kidney. 2nd ed. W. B. Saunders, PHiladelphia, 1981; p. 1351.

    Google Scholar 

  72. Gocke D. J., Hsu K., Morgan C., Bombardieri S., Lockshin M., Christian C. L.: Association between polyarteritis and Australia antigen — Lancetii, 1149, 1970.

    Google Scholar 

  73. Golbus S., Wilson C. B.: Experimental glomerulonephritis induced byin situ formation of immune complexes in glomerular capillary wall — Kidney int.16, 148, 1979.

    PubMed  CAS  Google Scholar 

  74. Goodman M. G.: Cellular aspects of polyclonal activation of B lymphocytes — Immunology Today, November 1980; p. 92.

  75. Grishman E., Churg J.: Focal glomerular sclerosis in nephrotic patients: an electron microscopic study of glomerular podocytes — Kidney int.7, 111, 1975.

    PubMed  CAS  Google Scholar 

  76. Hammer D. K., Dixon F. J.: Experimental glomerulonephritis. II. Immunologic events in the pathogenesis of nephrotoxic serum nephritis in the rat — J. exp. Med.117, 1019, 1963.

    PubMed  CAS  Google Scholar 

  77. Heidland A., Jult J., Rockel A., Heidbreder E.: Evaluation of essential amino acids and keto acids in uraemic patients on a low protein diet — Amer. J. clin. Nutr.31, 1784, 1978.

    PubMed  CAS  Google Scholar 

  78. Heptinstall R. H.: Pathology of the kidney — 1st ed., Little, Brown and Co., Boston, 1966; 2nd ed., 1974.

    Google Scholar 

  79. Holdsworth S. R., Neale T. J., Wilson C. B.: The participation of macrophages and monocytes in experimental immune complex glomerulonephritis — Clin. Immunol. Immunopath.15, 510, 1980.

    CAS  Google Scholar 

  80. Holdsworth S. R., Neale T. J., Wilson C. B.: Abrogation of macrophage-dependent injury in experimental glomerular injury in the rabbit. Use of an anti-macrophage serum — J. clin. Invest.68, 686, 1981.

    PubMed  CAS  Google Scholar 

  81. Hostetter T. H., Olson J. L., Rennke H. G., Venkatachalam M. A., Brenner B. M.: Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation — Amer. J. Physiol.241, F85, 1981.

    PubMed  CAS  Google Scholar 

  82. Hunsicker L. G., Shearer T. P., Plattner S. B., Weisenburger D.: The role of monocytes in serum sickness nephritis — J. exp. Med.150, 413, 1979.

    PubMed  CAS  Google Scholar 

  83. Ibels L. S., Alfrey A. C., Hant L., Huffer W. E.: Preservation of function in experimental renal disease by dietary restriction of phosphate — New Engl. J. Med.298, 122, 1978.

    PubMed  CAS  Google Scholar 

  84. Iversen B. M.: The effect of hypertension on experimental glomerulonephritis — Thesis, Bergen University, 1981.

  85. Iversen P., Brun C.: Aspiration biopsy of the kidney — Amer. J. Med.11, 324, 1951.

    PubMed  CAS  Google Scholar 

  86. Izui S., Lambert P. H., Fournié G. J., Türler H., Miescher P. A.: Features of systemic lupus erythematosus in mice injected with bacterial lipopolysaccharides. Identification of circulating DNA and renal localisation of DNA-anti-DNA complexes — J. exp. Med.145, 1115, 1977.

    PubMed  CAS  Google Scholar 

  87. Izui S., Lambert P. H., Miescher P. A.:In vitro demonstration of a particular affinity of glomerular basement membrane and collagen for DNA. A possible basis for local formation of DNA-anti-DNA complexes in systemic lupus erythematosus — J. exp. Med.144, 428, 1976.

    PubMed  CAS  Google Scholar 

  88. Jones D. B.: Inflammation and repair of the glomerulus — Amer. J. Path.27, 991, 1951.

    PubMed  CAS  Google Scholar 

  89. Karlinsky M. L., Haut L., Buddington B., Schrier N. A., Alfrey A. C.: Preservation of renal function in experimental glomerulonephritis — Kidney int.17, 293, 1980.

    PubMed  CAS  Google Scholar 

  90. Kibukamusoke J. W.: Nephrotic syndrome of quartan malaria — Edward Arnold, Bristol, 1973.

    Google Scholar 

  91. Kim Y., Michael A. F.: Chronic bacteremia and nephritis — Ann. Rev. Med.29, 319, 1978.

    PubMed  CAS  Google Scholar 

  92. Kincaid-Smith P.: Modification of the vascular lesions of rejection in cadaveric renal allografts by dipyridamole and anticoagulants — Lancetii, 920, 1969.

    Google Scholar 

  93. Kincaid-Smith P.: The kidney — Blackwell Sci. Publ., Oxford, 1975; p. 193.

    Google Scholar 

  94. Kincaid-Smith P., D’Apice A. J. F., Atkins R. C. (Eds): Progress in glomerulonephritis — John Wiley and Sons, New York, 1979.

    Google Scholar 

  95. Kincaid-Smith P., Mathew T. H., Becker E. L.: Glomerulonephritis. Morphology, natural history and treatment — John Wiley and Sons, New York, 1973.

    Google Scholar 

  96. Klouda P. T., Manos J., Acheson E. J., Dyer P. A., Goldby F. S., Harris R., Lawler W., Mallick N. P., Williams G.: Strong association between idiopathic membranous nephropathy and HLA-DRW3 — Lancetii, 770, 1979.

    Google Scholar 

  97. Kluthe R., Oechslin D., Quirin H., Jesdinsky H. J.: Six years experience with a special low-protein diet. In:Kluthe R., Berlyne G., Burton B. (Eds): Uraemia; pathogenesis, diagnosis and treatment. Thieme-Verlag, Stuttgart, 1971; p. 250.

    Google Scholar 

  98. Lambert P. H., Bricteux N., Salmon J., Miescher P. A.: Dynamics of immune complex nephritis during antibody excess — Int. Arch. appl. Immunol.45, 185, 1973.

    CAS  Google Scholar 

  99. Lange K., Ahmed U., Kleinberger H., Treser G.: A hitherto unknown streptococcal antigen and its probable relation to post-streptococcal glomerulonephritis — Clin. Nephrol.5, 207, 1976.

    PubMed  CAS  Google Scholar 

  100. Lawley T. J.: Immune complex and reticuloendothelial function in human disease — J. invest. Derm.74, 339, 1980.

    PubMed  CAS  Google Scholar 

  101. Lawrence G. M., Brewer D. B.: Effect of strain and sex on the induction of hyperalbuminaemic proteinuria in the rat — Clin. Sci.61, 751, 1981.

    PubMed  CAS  Google Scholar 

  102. Lee S., Kjellstrand C. M.: Renal disease in infectious mononucleosis — Clin. Nephrol.9, 236, 1978.

    PubMed  CAS  Google Scholar 

  103. Levinsky R. J., Malleson P. N., Barratt R. M., Soothill J. F.: Circulating immune complexes in steroid responsive nephrotic syndrome — New Engl. J. Med.298, 128, 1978.

    Google Scholar 

  104. Levy M., Kleinknecht C.: Membranous glomerulonephritis and hepatitis B infection — Nephron26, 259, 1980.

    PubMed  CAS  Google Scholar 

  105. Losito A., Buccarelli E., Masi-Benedetti F., Lato M.: Membranous glomerulonephritis in congenital syphilis — Clin. Nephrol.12, 32, 1979.

    PubMed  CAS  Google Scholar 

  106. Mannik M.: Physicochemical and functional relationships of immune complexes — J. invest. Derm.74, 333, 1980.

    PubMed  CAS  Google Scholar 

  107. Marchesi D., Parbtani A., Frampton G., Livio M., Remuzzi G., Cameron J. S.: Thrombotic tendency in systemic lupus erythematosus — Lanceti, 719, 1981. (Letter).

    Google Scholar 

  108. Masugi M.: Über die experimentelle Glomerulonephritis durch das spezifische Antireninserum. Ein Beitrag zur Pathogenese der diffusen Glomerulonephritis — Beitr. path. Anat.92, 429, 1934.

    Google Scholar 

  109. Mauer S. M., Sutherland D. E. R., Howard R. J., Fish A. J., Najarian J. S., Michael A. F.: The glomerular mesangium. III. Acute immune mesangial injury. A new model of glomerulonephritis — J. exp. Med.137, 553, 1973.

    PubMed  CAS  Google Scholar 

  110. McDevitt H. O., Bodmer W. F., Chinitz A.: HL-A, immune response gene and disease — Lanceti, 1269, 1974.

    Google Scholar 

  111. McIntosh R. W., Garcia R., Rubio L., Rabideau D., Allen J. E., Carr R. I., Rodriguez-Iturbe B.: Evidence for an autologous immune complex pathogenesis mechanism in acute post-streptococcal glomerulonephritis — Kidney int.14, 501, 1978.

    PubMed  CAS  Google Scholar 

  112. Mellors R. C., Arias-Stella J., Siegel M., Pressman D.: Analytical pathology. II. Histopathologic demonstration of glomerular-localizing antibodies in experimental glomerulonephritis — Amer. J. Path.31, 687, 1955.

    PubMed  CAS  Google Scholar 

  113. Michael A. F., Drummond K. N., Good R. A., Vernier R. L.: Acute post-streptococcal glomerulonephritis: immune deposit disease — J. clin. Invest.45, 237, 1966.

    PubMed  Google Scholar 

  114. Mitch W. E., Walser M., Buffington C. A., Lemann J.: A simple method for estimating progression of chronic renal failure — Lancetii, 1326, 1976.

    Google Scholar 

  115. Moller G., Strom H., Al-Balaghi S.: Role of polyclonal activation in specific immune responses — Scand. J. Immunol.12, 177, 1980.

    PubMed  CAS  Google Scholar 

  116. Morimoto C., Reinherz E. L., Schlossman S. F., Schur P. H., Mills J. A., Steinberg A. D.: Alterations in immunoregulatory T cell subsets in active systemic lupus erythematosus — J. clin. Invest.66, 1171, 1980.

    PubMed  CAS  Google Scholar 

  117. Morita T., Suzuki Y., Churg J.: Structure and development of the glomerular crescent — Amer. J. Path.72, 349, 1973.

    PubMed  CAS  Google Scholar 

  118. Muehrcke R. C., Kark R. M., Pirani C. L.: Technique of percutaneous renal biopsy in the prone position — J. Urol. (Baltimore)74, 267, 1955.

    CAS  Google Scholar 

  119. Naish P., Penn G. B., Evans D. J., Peters D. K.: The effects of defibrination of nephrotoxic nephritis in the rabbit — Clin. Sci.42, 643, 1972.

    PubMed  CAS  Google Scholar 

  120. Nakashima Y., Hirose S., Hamashima Y.: Proliferation of cultured rabbit renal glomerular cells stimulated by platelet factor — Acta path. jap.30, 1, 1980.

    PubMed  CAS  Google Scholar 

  121. Nathan C. F., Murray H. W., Cohn Z. A.: The macrophage as an effector cell — New Engl. J. Med.303, 622, 1980.

    PubMed  CAS  Google Scholar 

  122. Neild G. H., Gärtner H.-V., Bohle A.: Penicillamine-induced membranous glomerulonephritis — Scand. J. Rheum.28 (Suppl.), 79, 1979.

    Google Scholar 

  123. Nussenzweig V.: Interaction between complement and immune complexes: role of complement in containing immune complex damage. In:Fougereau M., Dausset J. (Eds): Immunology 80. Pergamon Press, New York, 1980; p. 1044.

    Google Scholar 

  124. Olson J. L., Hostetter T. H., Rennke H. G., Brenner B. M., Venkatachalam M. A.: Altered charge and size selective properties of the glomerular wall: a response to reduced renal mass — Kidney int.16, 857, 1979. (Abstract).

    Google Scholar 

  125. O’Regan S., Smith M., Drummond K. N.: Antigens in human immune complex nephritis — Clin. Nephrol.6, 417, 1976.

    PubMed  CAS  Google Scholar 

  126. Parbtani A., Cameron J. S.: Platelet involvement in glomerulonephritis. In:Remuzzi G., Mecca G., De Gaetano G. (Eds): Hemostasis, prostaglandins and renal disease. Raven Press, New York, 1980; p. 45.

    Google Scholar 

  127. Peters D. K., Lachmann P. J.: Immunity deficiency in pathogenesis of glomerulonephritis — Lanceti, 58, 1974.

    Google Scholar 

  128. Petty R. E., Steward M. W., Soothill J. F.: The heterogeneity of antibody affinity in inbred mice and its possible immunopathologic significance — Clin. exp. Immunol.12, 231, 1972.

    PubMed  CAS  Google Scholar 

  129. Pinto J., Lacerda G., Cameron J. S., Turner D. R., Bewick M., Ogg C. S.: Recurrence of focal segmental glomerulosclerosis in renal allografts — Transplantation32, 83, 1981.

    PubMed  CAS  Google Scholar 

  130. Poels L. G., Van Niekerk C. C., Jerusalem C.: Glomerulopathy in mice infected withPlasmodium berghei. Induction of an autoimmune process — Israel J. med. Sci.14, 651, 1978.

    PubMed  CAS  Google Scholar 

  131. Proceedings of a Symposium on immune complexes and disease — J. exp. Med.134 (Suppl.), 1s, 1971.

  132. Purtell J. N., Pesce A. J., Clyne D. H., Miller W., Pollak V.: Isoelectric point of albumin: effect on renal handling of albumin — Kidney int.16, 366, 1979.

    PubMed  CAS  Google Scholar 

  133. Ramzy M. H., Cameron J. S., Turner D. R., Neild G. H., Ogg C. S., Hicks J.: The long-term outcome of idiopathic membranous nephropathy — Clin. Nephrol.16, 13, 1981.

    PubMed  CAS  Google Scholar 

  134. Rees A. J., Peters D. K., Compston D. A. S., Batchelor J. R.: Strong association between HLA-DRW2 antibody-mediated Goodpasture’s syndrome — Lanceti, 966, 1978.

    Google Scholar 

  135. Rees A. J., Peters D. K., Welsh K., Batchelor J. R.: Genetic factors influence the severity of antibody-mediated Goodpasture’s syndrome. In: Abstracts, 8th Congr. Int. Soc. Nephrol., Athens, June 1981, no. CN-243; p. 303.

  136. Remuzzi G., Mecca G., De Gaetano G. (Eds): Hemostasis, prostaglandins and renal disease — Raven Press, New York, 1980.

    Google Scholar 

  137. Remuzzi G., Mecca G., Marchesi D., Livio M., De Gaetano G., Donati M. B., Silver M. J.: Platelet hyperaggregability and the nephrotic syndrome — Thrombos. Res.16, 345, 1979.

    CAS  Google Scholar 

  138. Roberts J. L., Lewis E. J.: Identification of anti-native DNA antibodies in cryoglobulinemic states — Amer. J. Med.65, 437, 1978.

    PubMed  CAS  Google Scholar 

  139. Rodriguez-Iturbe B., Carr R. I., Garcia R., Rabideau D., McIntosh R. M.: Circulating immune complexes and serum immunoglobulins in acute post-streptococcal glomerulonephritis — Clin. Nephrol.13, 1, 1980.

    PubMed  CAS  Google Scholar 

  140. Rodriguez-Iturbe B., Castillo L., Valbuena R., Cuenca L.: Acute post-streptococcal glomerulonephritis. Recent developments — Paediatrician8, 307, 1979.

    PubMed  CAS  Google Scholar 

  141. Rodriguez-Iturbe B., Rabideau D., Garcia R., Rubio L., McIntosh R. M.: Characterization of the glomerular antibody in acute post-streptococcal glomerulonephritis — Ann. intern. Med.92, 478, 1980.

    PubMed  CAS  Google Scholar 

  142. Rosenthal A. S.: Regulation of the immune response: role of the macrophage — New Engl. J. Med.303, 1153, 1980.

    PubMed  CAS  Google Scholar 

  143. Ross R., Vogel A.: The platelet-derived growth factor. (Review) — Cell14, 203, 1978.

    PubMed  CAS  Google Scholar 

  144. Rudofsky U. H.: Murine lupus nephritis is accelerated by anti-glomerular basement membrane antibodies — Clin. exp. Immunol.44, 18, 1981.

    PubMed  CAS  Google Scholar 

  145. Rutherford W. E., Blondin J., Miller J. P., Greenwalt A. S., Vaura J. D.: Chronic progressive renal disease: rate of change of serum creatinine — Kidney int.11, 62, 1977.

    PubMed  CAS  Google Scholar 

  146. Salant D. J., Belok S., Madaio M. P., Couser W. G.: A new role for complement in experimental membranous nephropathy in rats — J. clin. Invest.66, 1339, 1980.

    PubMed  CAS  Google Scholar 

  147. Schifferli J. A., Morris S. M., Dash A., Peters D. K.: Complement-mediated solubilisation in patients with systemic lupus erythematosus, nephritis or vasculitis — Clin. exp. Immunol.46, 557, 1981.

    PubMed  CAS  Google Scholar 

  148. Schreiner G. F., Cotran R. S., Pardo V., Unanue E. R.: A mononuclear cell component in experimental glomerulonephritis — J. exp. Med.147, 369, 1978.

    PubMed  CAS  Google Scholar 

  149. Schreiner G. F., Cotran R. S., Unanue E. R.: Glomerular cell types and immune function. In: Proc. 8th Congr. Int. Soc. Nephrol., Athens, June 1981. Karger, Basel, 1981; p. 858.

    Google Scholar 

  150. Schreiner G. F., Cotran R. S., Unanue E. R.: Characterisation of resident glomerular cells in the rat expressing Ia determinants and manifesting genetically restricted interactions with lymphocytes — J. clin. Invest.68, 920, 1981.

    PubMed  CAS  Google Scholar 

  151. Seligson G., Lange K., Cronin W.: Evidence for thein situ origin of post-streptococcal glomerulonephritis. In: Abstracts, American Society of Nephrology, Washington, November 1981; p. 86A.

  152. Shaw S., Kavathas P., Pollack M. S., Charmot D., Mawas C.: Family studies define a new histocompatibility locus, SB, between HLA-DR and GLO — Nature (Lond.)293, 745, 1981.

    CAS  Google Scholar 

  153. Shigematsu H.: Glomerular events during the initial phase of rat Masugi nephritis — Virchows Arch. Abt. B5, 187, 1970.

    CAS  Google Scholar 

  154. Shigematsu H., Niwa Y., Takizawa J., Akikusa B.: Arthus type nephritis. I. Characterisation of glomerular lesions induced by insoluble and poorly soluble immune complexes — Lab. Invest.40, 492, 1979.

    PubMed  CAS  Google Scholar 

  155. Shigematsu H., Shishido H., Kuhara K., Tsuchida H., Suzuki H., Hirose K., Tojo S.: Participation of monocytes in transient glomerular hypercellularity in post-streptococcal glomerulonephritis — Virchows Arch. Abt. B12, 367, 1973.

    CAS  Google Scholar 

  156. Shimamura T., Morrison A. B.: A progressive glomerulosclerosis occurring in partial five-sixths nephrectomy — Amer. J. Path.79, 95, 1975.

    PubMed  CAS  Google Scholar 

  157. Sitprija V., Pipatanagul V., Boonpucknavig V., Boonpucknavig S.: Glomerulitis in typhoid fever — Ann. intern. Med.81, 210, 1974.

    PubMed  CAS  Google Scholar 

  158. Steinman C. R.: Circulating DNA in systemic lupus erythematosus. Association with central nervous system vasculitis — Amer. J. Med.67, 429, 1979.

    PubMed  CAS  Google Scholar 

  159. Stejskal J., Pirani C. L., Okade M., Mandelanakis N., Pollak V. E.: Discontinuities (gaps) of the glomerular capillary wall and basement membrane in renal diseases — Lab. Invest.28, 149, 1973.

    PubMed  CAS  Google Scholar 

  160. Svejgaard A., Morling N., Platz P., Ryder C. P., Thomson M.: HLA disease. In:Fougereau M., Dausset J. (Eds): Immunology 80. Pergamon Press, New York, 1980; p. 530.

    Google Scholar 

  161. Swaak A. J., Aarden L. A., Statius Van Eps L. W., Feltkamp T. E.: Anti-dsDNA and complement profiles as prognostic guides in systemic lupus erythematosus — Arthr. and Rheum.22, 226, 1979.

    CAS  Google Scholar 

  162. Takahashi M., Takahashi S., Brade V., Nussenzweig V.: Requirements for the solubilisation of immune aggregates by complement. The role of the classical pathway — J. clin. Invest.62, 349, 1978.

    PubMed  CAS  Google Scholar 

  163. Tarantino A., De Vecchi A., Montagnino G., Imbasciati E., Mihatsch M. J., Zollinger H. O., Di Belgiojoso G. B., Busnach G., Ponticelli C.: Renal disease in essential mixed cryoglobulinaemia. Long-term follow-up of 44 cases — Quart. J. Med.46, 1, 1981.

    Google Scholar 

  164. Theophilopoulos A. N., Dixon F. J.: The biology and detection of immune complexes — Advanc. Immunol.28, 117, 1979.

    Google Scholar 

  165. Thomson N. M., Holdsworth S. R., Glasgow E. F., Atkins R. C.: The macrophage in the development of experimental crescentic glomerulonephritis — Amer. J. Path.94, 223, 1979.

    PubMed  CAS  Google Scholar 

  166. Thomson N. M., Holdsworth S. R., Glasgow E. F., Peters D. K., Atkins R. C.: Mechanisms of injury in experimental glomerulonephritis. In:Kincaid-Smith P., D’Apice A. J. F., Atkins R. C. (Eds): Progress in glomerulonephritis. John Wiley and Sons, New York, 1979; p. 51.

    Google Scholar 

  167. Tikkanen I., Tornroth T., Miettinen A., Fyhrqvist F.: Heymann nephritis — DOCA — NaCl hypertension in the rat. Role of nephritis, DOCA, NaCl and vascular lesions in the development of hypertension — Nephron28, 90, 1981.

    PubMed  CAS  Google Scholar 

  168. Trevillian P., Cameron J. S.: The interaction of antiglomerular basement membrane antibody deposition with immune elimination of bovine serum albumin in the rabbit — Clin. exp. Immunol.35, 338, 1979.

    PubMed  CAS  Google Scholar 

  169. Van Damme B. J. C., Fleuren G. J., Bakker W. W., Vernier R. L., Hoedemaker P. H. J.: Experimental glomerulonephritis in the rat induced by antibodies directed against tubular antigens — Lab. Invest.38, 502, 1978.

    PubMed  Google Scholar 

  170. Van Es L. A., Block A. P. R., Schoenfeld L., Glassock R. J.: Chronic nephritis induced antibodies reacting with glomerular-bound immune complexes — Kidney int.11, 106, 1977.

    PubMed  Google Scholar 

  171. Vassalli P., McCluskey R. T.: The pathogenic role of the coagulation process in rabbit Masugi nephritis — Amer. J. Path.45, 653, 1964.

    PubMed  CAS  Google Scholar 

  172. Vermylen J., Defreyn G., Carreras L. O., Machin S. J., Schaeren J. V., Verstraete M.: Thromboxane synthetase inhibition as anti-thrombotic strategy — Lanceti, 1073, 1981.

    Google Scholar 

  173. Walser M.: Ketoacids in the treatment of uraemia — Clin. Nephrol.3, 180, 1975.

    PubMed  CAS  Google Scholar 

  174. Wardle E. N.: The role of platelets in glomerulonephritis and transplantation — J. roy. Coll. Phycns Lond.7, 5, 1972.

    CAS  Google Scholar 

  175. Whittle B. J. R., Moncada S., Whiting F., Vane T. R.: Carbacyclin — a potent stable prostacyclin analogue for the inhibition of platelet aggregation — Prostaglandins19, 605, 1980.

    PubMed  CAS  Google Scholar 

  176. Williams R. C.: A second look at rheumatoid factor and other ‘autoantibodies’ — Amer. J. Med.67, 179, 1979.

    PubMed  Google Scholar 

  177. Wilson C. B.: Nephritogenic antibody mechanisms involving antigens within the glomerulus — Immunol. Rev.55, 257, 1981.

    PubMed  CAS  Google Scholar 

  178. Wilson C. B., Dixon F. J.: The quantitation of acute and chronic serum sickness in the rabbit — J. exp. Med.134, 7s, 1971.

  179. Wilson C. B., Dixon F. J.: The renal response to immunological injury. In:Brenner B. M., Rector F. C. (Eds): The kidney. 2nd ed., W. B. Saunders, Philadelphia, 1981; p. 1237.

    Google Scholar 

  180. Winfield J. B., Faiterman I., Koffler D.: Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. Association of high avidity antibody with glomerulonephritis — J. clin. Invest.59, 90, 1977.

    PubMed  CAS  Google Scholar 

  181. Wolstenholme G. E. W., Cameron M. P. (Eds): Renal biopsy. Clinical and pathological significance — Ciba Foundation Symposium, London, 1961.

    Google Scholar 

  182. Zimmerman T. S.: The coagulation mechanism and the inflammatory response. In:Miescher P. A., Muller-Eberhard H. E. (Eds): Clinical immunopathology. Grune and Stratton, New York, 1976; p. 95.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Lecture given in Bergamo (Italy) on February 27, 1982, at the Symposium on ‘Pathogenesis of Glomerulonephritis’ devoted to the 300th anniversary of Morgagni’s birth.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cameron, J.S. The pathogenesis of glomerulonephritis. La Ricerca Clin. Lab. 12, 539–564 (1982). https://doi.org/10.1007/BF02909340

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02909340

Key-words

Navigation